Multidrug-resistant Bacteroides fragilis - Seattle, Washington, 2013

Morbidity and Mortality Weekly Report

Volumn 62, Issue 34, 2013, Pages 694-696

  Kalapila, Aley ^a   Pergam, Steven ^a   Pottinger, Paul ^a   Butler Wu, Susan ^a   Whimbey, Estella ^a   Duchin, Jeffrey ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

AGED; ARTICLE; BACTEROIDES FRAGILIS; BACTEROIDES INFECTION; CASE REPORT; COLON TUMOR; DRUG EFFECT; HUMAN; INDIA; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; TRAVEL; UNITED STATES;

AGED; ANTI-BACTERIAL AGENTS; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; COLONIC NEOPLASMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; TRAVEL; WASHINGTON;

EID: 84883337744     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Snydman DR, Jacobus NV, McDermott LA, et al. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Clin Infect Dis 2010;50: S26-33.
2. Nagy E, Urban E, Nord CE, ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect 2011;17:371-9.
3. CDC. New carbapenem-resistant Enterobacteriaceae warrant additional action by healthcare providers. CDC Health Alert Network. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at http://emergency.cdc.gov/han/han00341.asp.
4. Wareham DW, Wilks M, Ahmed D, Brazier JS, Millar M. Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis; microbiological cure and clinical response with linezolid therapy. Clin Infect Dis 2005; 40:e67-8.
5. Soki J, Eitel Z, Urban E, Nagy E, ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. Molecular analysis of the carbapenem and metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey. Int J Antimicrob Agents 2013;41:122-5.
6. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011; 53:60-7.
7. Chaudhry R, Mathur P, Dhawan B, Kumar L. Emergence of metronidazole-resistant Bacteroides fragilis, India. Emerg Infect Dis 2001; 7:485-6.
8. Sherwood JE, Fraser S, Citron DM, et al. Multidrug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan. Anaerobe 2011; 17:152-5.
9. Clinical Laboratory Standards Institute. Methods of antimicrobial susceptibility testing of anaerobic bacteria; approved standards. M11-A7. Wayne, PA: Clinical Laboratory Standards Institute; 2007.
10. Schapiro JM, Gupta R, Stefansson E, Fang FC, Limaye AP. Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington state. J Clin Microbiol 2004;42:4127-9.